Skip to content

Three Quick Facts: BT Group, Pearson and Reckitt Benckiser

Three Quick Facts: BT Group, Pearson and Reckitt Benckiser

BT Group

We’ve got a Q1 trading update from the complicated corporate beast that is BT Group this morning. It’s regulatory challenges that have presented the biggest hurdles to the company in recent years, so investors may be willing to overlook the 2% drop in revenues when compared to a year ago. Critically however, it’s a case of asking whether the regulatory influence is now coming to an end. The company certainly seems to be making the most of its acquisition of EE, with mobile performance looking like something of a stand out. Expectations for the full year remain unchanged.

Pearson

Educational publisher Pearson has issued half year numbers this morning, which shows some welcome relief for a business which has at times struggled in recent years. Revenues are up 2% but adjusted profits have leapt 46%, debt is being paid down quickly and the interim dividend has been lifted 10%, too. The company expects to deliver underlying profit growth for the full year.

Reckitt Benckiser

Healthcare and household goods group Reckitt Benckiser – the owners of everything from Nurofen to Durex and Cillit Bang – have released their half year results and there’s no shortage of good news here. Acquisitions have delivered much of the revenue growth, but critically the company is upgrading its like for like projections for the full year. Revenues are expected to be 1-2% higher than previously expected and it’s news like this that will likely give shareholders cause to cheer.

Share this article

Invest with these platforms

Hargreaves Lansdown

IG

Interactive Brokers

Interactive Investor

Charles Stanley

IG

Interactive Brokers

Charles Stanley

Looking for great investing ideas? Get our free newsletter.

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
Schroders

aberdeen
WisdomTree
ARK
Plus500
CMC Markets
Back To Top